References
- American Psychiatric Association (2013)). Diagnostic and statistical manual of mental disorders (DSM-5). Washington: American Psychiatric Publishing
- Andrews, G.J. (2011). ‘I had to go to the hospital and it was freaking me out’: Needlephobic encounter space. Health & Place, 17, 875–884. https://dx.doi.org/10.1016/j.healthplace.2011.04.012
- Ayala, E.S., Meuret, A.E., & Ritz, T. (2009). Treatments for blood-injury-injection phobia: A critical review of current evidence. Journal of Psychiatric Research, 43, 1235–1242. http://dx.doi.org/10.1016/j.jpsychires.2009.04.008
- Bassons, C. (2000). Positif. Paris: Éditions Stock
- Bastide, R. (1970). Doping: les surhommes du vélo. Paris: Solar
- Bobet, J. (2012). Mañana salimos. Senan: Cultura Ciclista
- De Lignières, B., & Saint-Martin, E. (1999): Vive le dopage? Paris: Flammarion
- De Mondenard, J.P. (2011). Tour de France. 33 vainqueurs face au dopage. Paris: Hugo et Compagnie
- Dimeo, P. (2007). A history of drug use in sport: 1876–1976: Beyond good and evil. London: Routledge
- Fignon, L., & Ducoin, J.E. (2009). Nous étions jeunes et insouciants. Paris: Grasset
- Gleaves, J., & Llewellyn, M. (2013). Sport, drugs and amateurism: Tracing the real cultural origins of anti-doping rules in international sport”. International Journal of the History of Sport, 31, 839–853. http://dx.doi.org/10.1080/09523367.2013.831838
- Guimard, C., & Ducoin, J.E. (2012). Dans les secrets du Tour de France. Paris: Grasset
- Hamilton, J.G. (1995). Needle phobia: A neglected diagnosis. The Journal of Family Practice, 41, 169–175
- Hunt, T. (2011). Drug games: The international Olympic committee and the politics of doping, 1960–2008. Austin: University of Texas Press
- Kayser, B., Mauron, A., & Miah, A. (2007). Current anti-doping policy: A critical appraisal. BMC Medical Ethics, 8, 2. https://dx.doi.org/10.1186/1472-6939-8-2
- Kimmage, P. (2007). Rough ride. London: Yellow Jersey Press
- König, E. (1995). Criticism of doping: The nihilistic side of technological sport and the antiquated view of sport ethics. International Review for the Sociology of Sport, 30, 247. https://dx.doi.org/10.1177/101269029503000302
- Kose, S., & Mandiracioglu, A. (2007). Fear of blood/injection in healthy and unhealthy adults who are admitted to a teaching hospital. International Journal of Clinical Practice, 61, 453–457. https://dx.doi: 10.1111/j.1742-1241.2006.01150.x
- Laplanche, J., & Pontalis, J.B. (1996). Diccionario de psicoanálisis. Barcelona: Paidós
- LoBue, V. (2010). What's so scary about needles and knives? Examining the role of experience in threat detection. Cognition & Emotion, 24, 180–187. http://dx.doi.org/10.1080/02699930802542308
- López, B. (2011). The invention of a ‘Drug of Mass Destruction’: Deconstructing the EPO myth. Sport in History, 31, 84–109. http://dx.doi.org/10.1080/17460263.2011.555208
- López, B. (2013). Creating fear: The social construction of human Growth Hormone as a dangerous doping drug. International Review for the Sociology of Sport, 48, 220–237. http://dx.doi.org/10.1177/1012690211432209
- López, B. (2014a). ‘The Good, Pure Old Days’: Cyclist's switching appraisals of doping before and after retirement as claims making in the construction of doping as a social problem. International Journal of the History of Sport, 31, 2141–2157. http://dx.doi.org/10.1080/09523367.2014.911731
- López, B. (2014b). Creating fear: the ‘doping deaths’, risk communication and the anti-doping campaign. International Journal of Sport Policy and Politics, 6, 213–225. http://dx.doi.org/10.1080/19406940.2013.773359
- Mazanov, J., & Connor, J. (2010). Rethinking the management of drugs in sport. International Journal of Sport Policy and Politics, 2, 49–63. http://dx.doi.org/10.1080/19406941003634032
- Møller, V. (2005). Knud Enemark Jensen's death during the 1960 Rome Olympics: A search for truth? Sport in History, 25, 452–471. http://dx.doi.org/10.1080/17460260500396319
- Møller, V. (2008). The doping devil. Copenhagen: Books on Demand
- Møller, V. (2009). The ethics of doping and anti-doping. London: Routledge
- Møller, V. (2011). Editorial – UCI no needle policy. Retrieved from http://ph.au.dk/fileadmin/ph/Idraet/INHDR/Resources/Verner_Moeller_-_May_2011_-_INHDR_editorial.pdf (Accessed August 2014)
- Nir, Y., Paz, A., Sabo, E., & Potasman, I. (2003). Fear of injections in young adults: Prevalence and associations. American Journal of Tropical Medicine and Hygiene, 68, 341–344
- Noyes, R., Hartz, A.J., Doebbeling, C.C., Malis, R.W., Happel, R.L., Werner, L.A., & Yagla, S.J., et al. (2000). Illness fears in the general population. Psychosomatic Medicine, 62, 318–325
- Puri, B.K. (2007). Blood-injection-injury phobias. International Journal of Clinical Practice, 61, 358–359. http://dx.doi.org/10.1111/j.1742-1241.2006.01149.x
- Riis, B. & Pedersen, L.S. (2012). Riis. Stages of light and dark. London: Vision Sports Publishing
- Savulescu, J., Foddy, B., & Clayton, M. (2004). Why we should allow performance enhancing drugs in sport. British Journal of Sports Medicine, 38, 666–670. http://dx.doi.org/10.1136/bjsm.2003.005249
- Tamburrini, C. (2000). What’s wrong with doping?. In C. Tamburrini, & T. Torbjörn (Eds.), Values in sport. Elitism, nationalism gender equality and the scientific manufacture of winners. London, New York: E&FN Spon
- Tamburrini, C. (2007). “Are doping sanctions justified? A moral relativistic view”. In A.J. Schneider, & Fan Hong (Eds.), Doping in sport. Global ethical issues. Abingdon: Routledge
- Waddington, I. (1996). The development of sports medicine. Sociology of Sport Journal, 13, 176–196. http://dx.doi.org/10.1123/ssj.13.2.176
- Waddington, I., & Smith, A. (2008). An introduction to drugs in sport: Addicted to winning? London: Routledge
- Willemsen, H., Chowdhury, U., & Briscall, L. (2002). Needle phobia in children: A discussion of aetiology and treatment options. Clinical Child Psychology and Psychiatry, 7, 609–619. doi: 10.1177/1359104502007004012
- Wright, S., Yelland, M., Heathcote, K. & Ng, S. (2009). Fear of needles. Nature and prevalence in general practice. Australian Family Physician, 38, 172–176